The changes in the concentration of organokines are not unidirectional, i.e., the levels of protective organokines decrease and the harmful ones increase during the progress of obesity, but the levels of certain protective organokines may show a compensatory increase, such as in the case of PEDF, PGRN or ghrelin. The gene discussed is GHRL; the disease is Obesity.